Transplantation of human thioredoxin gene-modified hepatocytes for treatment of acute liver failure in rat model

Chinese Medical Journal

Volumn 122, Issue 21, 2009, Pages 2631-2635

  Li, Hua ^a   Jiang, Nan ^a   Zhang, Jian ^a   Wang, Gen Shu ^a   Yang, Yang ^a   Chen, Gui Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gene expression; Hepatocyte; Liver failure, acute; Thioredoxin; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; BILIRUBIN; COMPLEMENTARY DNA; HYBRID PROTEIN; RETROVIRUS VECTOR; THIOREDOXIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL CULTURE; CELL STRAIN 3T3; CELL TRANSPLANTATION; DNA MODIFICATION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; NONHUMAN; OSTEOSARCOMA CELL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; SURVIVAL RATE; VIRUS TITRATION;

ANIMALS; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; MICE; NIH 3T3 CELLS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOREDOXINS;

EID: 73449085188     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.21.020     Document Type: Article

References (11)

1. Kondo N, Nakamura H, Masutani H, Yodoi J. Redox regulation of human thioredoxin network. Antioxid Redox Signal 2006; 8: 1881-1890.
2. Li H, Chen GH, Lu MQ, Yang Y, Cai CJ, Xu C, et al. Recombinant human thioredox influences survival and growth in primary cultured hepatocytes. Chin J Gen Surg (Chin) 2005; 20: 803-806.
3. Weber A, Groyer-Picard MT, Franco D, Daqher I. Hepatocyte transplantation in animal models. Liver Transpl 2009; 15: 7-14.
4. Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J Gastroenterol 2009; 44: 167-172.
5. Tao L, Gao E, Hu A, Coletti C, Wang Y, Christopher TA, et al. Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol 2006; 149: 311-318.
6. Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Matsumoto S, et al. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. Cell Transplant 2008; 17: 1083-1094.
7. Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, et al. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J Hepatol 2007; 47: 74-82.
8. Karnezis AN, Dorokhov M, Grompe M, Zhu L. Loss of p27 (Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J Clin Invest 2001; 108: 383-390.
9. Kosone T, Takagi H, Horiguchi N, Kakizaki S, Sato K, Watanabe Y, et al. Transforming growth factor-alpha accelerates hepatocyte repopulation after hepatocyte transplantation. J Gastroenterol Hepatol 2008; 23: 260-266.
10. Wang X, Mani P, Sarkar DP, Roy-Chowdhury N, Roy-Chowdhury J. Ex vivo gene transfer into hepatocytes. Methods Mol Biol 2009; 481: 117-140.
11. Akhter J, Johnson LA, Gunasegaram A, Riordan SM, Morris DL. Hepatocyte transplantation: a review of laboratory techniques and clinical experiences. Surgeon 2007; 5: 155-164.